Brickell Biotech Inc operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Brickell Biotech Inc with three other
companies in this sector in the United States:
sales of $1.14 million
Windtree Therapeutics Inc
Idera Pharmaceuticals, Inc.
of which 100%
was Novel Therapeutics).
Sales fell dramatically in 2018:
Brickell Biotech Inc reported sales of $1.62 million
December of 2018.
decrease of 88.3%
versus 2017, when the company's sales were $13.82 million.